Carolyn Finkle Audio Interview

Catalent Eyes Emerging Market Expansion of End-To-End Development Service Model

Author: Outsourcing Pharma

Catalent's own Carolyn Finkle, Vice President, Regulatory Consulting, spoke to Outsourcing Pharma at DIA Europe about recent expansions in the UK and Germany. Carolyn also discusses plans to offer end-to-end drug development services globally with a focus on emerging markets.

Click here to listen to the interview